{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:10Z","timestamp":1793633470542,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272964"],"award-info":[{"award-number":["82272964"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103070","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:01:03Z","timestamp":1791622863000},"page":"103070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis\/relapse in osteosarcoma"],"prefix":"10.1016","volume":"74","author":[{"given":"Zhangfu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5991-9036","authenticated-orcid":false,"given":"Shiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-0562","authenticated-orcid":false,"given":"Shengji","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.tranon.2026.103070_bib0001","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.annonc.2021.08.1995","article-title":"Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up","volume":"32","author":"Strauss","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0002","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2026.103070_bib0003","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.0017","article-title":"Bone cancer, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Biermann","year":"2025","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"7","key":"10.1016\/j.tranon.2026.103070_bib0004","first-page":"23","article-title":"Recent and ongoing research into metastatic osteosarcoma treatments","author":"Harris","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.tranon.2026.103070_bib0005","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1002\/cam4.6409","article-title":"Solitary pulmonary metastases at first recurrence of osteosarcoma: presentation, treatment, and survival of 219 patients of the cooperative osteosarcoma study group","volume":"12","author":"Mettmann","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2026.103070_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100281","article-title":"Prognostic factors in osteosarcoma: a study level meta-analysis and systematic review of current practice","volume":"21","author":"Xin","year":"2020","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.tranon.2026.103070_bib0007","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American osteosarcoma study) cohort","volume":"109","author":"Smeland","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/2159-8290.CD-17-1152","article-title":"Genome-informed targeted therapy for osteosarcoma","volume":"9","author":"Sayles","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0009","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1038\/s41467-022-34689-5","article-title":"Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.tranon.2026.103070_bib0010","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.7150\/jca.32092","article-title":"Co-expression network analysis identified gene signatures in osteosarcoma as a predictive tool for lung metastasis and survival","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"issue":"11","key":"10.1016\/j.tranon.2026.103070_bib0011","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1007\/s12033-023-00681-7","article-title":"Metastasis-related signature for clinically predicting prognosis and tumor immune microenvironment of osteosarcoma patients","volume":"65","author":"Zhang","year":"2023","journal-title":"Mol. Biotechnol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-023-00917-3","article-title":"A tumor microenvironment-based prognostic index for osteosarcoma","volume":"30","author":"Wu","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0013","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.tranon.2026.103070_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1394284","article-title":"Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms","volume":"15","author":"Orrapin","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.tranon.2026.103070_bib0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103070_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/v13061102","article-title":"HERC5 and the ISGylation pathway: critical modulators of the antiviral immune response","volume":"13","author":"Mathieu","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0017","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103070_bib0018","article-title":"Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.103070_bib0019","article-title":"Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.tranon.2026.103070_bib0020","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1158\/0008-5472.CAN-24-3360","article-title":"Metastasis-initiating osteosarcoma subpopulations establish paracrine interactions with lung and tumor cells to create a metastatic niche","volume":"85","author":"Reinecke","year":"2025","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2026.103070_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/10225536231177102","article-title":"Clinical model of pulmonary metastasis in patients with osteosarcoma: a new multiple machine learning-based risk prediction","volume":"31","author":"Su","year":"2023","journal-title":"J. Orthop. Surg. (Hong. Kong)"},{"key":"10.1016\/j.tranon.2026.103070_bib0022","article-title":"Osteosarcoma immune prognostic index can indicate the nature of indeterminate pulmonary nodules and predict the metachronous metastasis in osteosarcoma patients","volume":"12","author":"He","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2026.103070_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28493","article-title":"Advances in prognostic models for osteosarcoma risk","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0024","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13018-022-03386-w","article-title":"Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis","volume":"17","author":"Liao","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.tranon.2026.103070_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.699212","article-title":"A novel six metastasis-related prognostic gene signature for patients with osteosarcoma","volume":"9","author":"Zheng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0026","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1038\/s41598-020-61236-3","article-title":"MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma","volume":"10","author":"Lietz","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103070_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1394339","article-title":"Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies","volume":"12","author":"Liang","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2026.103070_bib0028","article-title":"New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.103070_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/srep30093","article-title":"Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma","volume":"6","author":"Koirala","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103070_bib0030","article-title":"Classification of osteosarcoma based on immunogenomic profiling","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2026.103070_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class i antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.tranon.2026.103070_bib0032","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1074\/jbc.M512830200","article-title":"Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells","volume":"281","author":"Dastur","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3\u20134","key":"10.1016\/j.tranon.2026.103070_bib0033","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103070_bib0034","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/BST20210961","article-title":"Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance","volume":"50","author":"Balasubramanian","year":"2022","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.tranon.2026.103070_bib0035","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","article-title":"Biological consequences of MHC-II expression by tumor cells in cancer","volume":"25","author":"Axelrod","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0036","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.tranon.2026.103070_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21055","article-title":"Role of osteopontin in cancer development and treatment","volume":"9","author":"Yan","year":"2023","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.tranon.2026.103070_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16091773","article-title":"MIF and CD74 as emerging biomarkers for immune checkpoint blockade therapy","volume":"16","author":"Fey","year":"2024","journal-title":"Cancers. (Basel)"},{"issue":"6","key":"10.1016\/j.tranon.2026.103070_bib0039","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.tranon.2026.103070_bib0040","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.tranon.2026.103070_bib0041","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11864-020-00760-w","article-title":"Role of TKI for metastatic osteogenic sarcoma","volume":"21","author":"Duffaud","year":"2020","journal-title":"Curr. Treat. Options. Oncol."},{"key":"10.1016\/j.tranon.2026.103070_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.tranon.2026.103070_bib0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann. Intern. Med."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:13:45Z","timestamp":1793632425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326004067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S1936523326004067"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103070","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis\/relapse in osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103070"}}